Late events in reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with alemtuzumab (CAMPATH-1H) containing regimens impact on outcome compared with standard myeloablative conditioning.

A Y L Ho, M Kenyon, J E Parker, I El-Hemaidi, M Zuckerman, S Devereux, A Pagliuca, G J Mufti

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)1605
Number of pages1
JournalBlood
Volume100
Issue number11
Publication statusPublished - 2002
Event44th Annual Meeting of the American-Society-of-Hematology - PHILADELPHIA, PENNSYLVANIA
Duration: 1 Jan 2002 → …

Cite this